555.00
-12.70
(-2.24%)
As of 10:16:45 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 44 | 36 | 54 | 59 |
| Avg. Estimate | 38.04B | 42.07B | 129.14B | 196.05B |
| Low Estimate | 36.35B | 39.4B | 123.66B | 164.23B |
| High Estimate | 42.08B | 46.96B | 133.33B | 252.62B |
| Year Ago Sales | 22.1B | 26.04B | 60.92B | 129.14B |
| Sales Growth (year/est) | 72.09% | 61.55% | 111.97% | 51.81% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVDA.WA | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Rosenblatt: Buy to Buy | 1/8/2025 |
| Reiterates | Benchmark: Buy to Buy | 1/7/2025 |
| Maintains | DA Davidson: Neutral to Neutral | 11/22/2024 |
| Downgrade | Phillip Securities: Buy to Accumulate | 11/22/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/21/2024 |
| Maintains | Wedbush: Outperform to Outperform | 11/21/2024 |